Your browser doesn't support javascript.
Impact of IFN- β1a in treatment of a COVID-19 Patient with Beta Thalassemia and Diabetes Mellitus: A Case Report (preprint)
authorea preprints; 2022.
Preprint in English | PREPRINT-AUTHOREA PREPRINTS | ID: ppzbmed-10.22541.au.164448560.01591917.v1
ABSTRACT
The present study aimed to report a case with COVID-19 with a history of chronic diseases, beta thalassemia intermedia, and DM. A 25-year-old man visited with covid 19 and treatment with IFN-β1a. According to the present report, the use of IFN-β1a was effective as a treatment option for COVID-19.
Subject(s)

Full text: Available Collection: Preprints Database: PREPRINT-AUTHOREA PREPRINTS Main subject: Chronic Disease / Beta-Thalassemia / Diabetes Mellitus / COVID-19 / Myotonic Dystrophy Language: English Year: 2022 Document Type: Preprint

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Preprints Database: PREPRINT-AUTHOREA PREPRINTS Main subject: Chronic Disease / Beta-Thalassemia / Diabetes Mellitus / COVID-19 / Myotonic Dystrophy Language: English Year: 2022 Document Type: Preprint